IP Verse

Piperazine Derivatives As Fasn Inhibitors - EP2976328

The patent EP2976328 was granted to Merck Patent on Jul 3, 2019. The application was originally filed on Feb 24, 2014 under application number EP14708800A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2976328

MERCK PATENT
Application Number
EP14708800A
Filing Date
Feb 24, 2014
Status
Patent Maintained As Amended
May 31, 2019
Grant Date
Jul 3, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

EIPFeb 2, 2018EIPADMISSIBLE
FH SERVICESFeb 2, 2018BECK GREENERADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTWO2011048018
OPPOSITIONCN102627610
OPPOSITIONUS2009197863
OPPOSITIONUS6492368
OPPOSITIONWO2008099000
OPPOSITIONWO2014164749

Non-Patent Literature (NPL) Citations (13) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20070320), Database accession no. 927570-20-5, URL: STN, XP002722801 [X] 1-7 * 927570-20-5 *-
INTERNATIONAL-SEARCH-REPORT- REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20080413), Database accession no. 1014245-05-6, URL: STN, XP002722800 [X] 1-7 * 1014245-05-6 *-
INTERNATIONAL-SEARCH-REPORT- REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20120808), Database accession no. 1387900-07-3, URL: STN, XP002722731 [X] 1-7 * 1387900-07-3 *-
INTERNATIONAL-SEARCH-REPORT- HEE-KYUNG RHEE ET AL, "Synthesis and cytotoxicity of 2-phenylquinazolin-4(3)-one derivatives", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 46, no. 9, doi:10.1016/J.EJMECH.2011.05.061, ISSN 0223-5234, (20110524), pages 3900 - 3908, (20110531), XP028278287 [A] 1-14 * table 1 *
OPPOSITION- "1 Heterocyclic Nomenclature", John A. JOULE, Keith Mills, Heterocyclic Chemistry Fifth Edition, John Wiley & Sons, Inc., (20100000), pages 3pp, 1 - 3, XP055459406-
OPPOSITION- Registry, Chemical Abstracts Service, (20070320), Database accession no. 927570-20-5, URL: REGISTRY; STN, XP002722801-
OPPOSITION- Registry, Chemical Abstracts Service, (20080413), Database accession no. 014245-05-6, URL: REGISTRY; STN, XP002722800-
OPPOSITION- Registry, Chemical Abstracts Service, (20120808), Database accession no. 1387900-07-3, URL: REGISTRY; STN, XP002722731-
OPPOSITION- REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO,, (20070320), Database accession no. 927570-20-5, XP002722801-
OPPOSITION- REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, (20080413), Database accession no. 1014245-05-6, XP002722800-
OPPOSITION- REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO,, (20120808), Database accession no. 1387900-07-3, XP002722731-
OPPOSITION- "Summary, the three major approaches to the synthesis of aromatic heterocycles", CLAYDEN et al., Clyden, Greeves, Warren and Wothers Organic Chemistry, Oxford University Press, (20010000), pages 2pp, 1214 - 1215, XP055459413-
OPPOSITION- HEE-KYUNG RHEE et al., "Synthesis and cytotoxicity of 2-phenylquinazolin- 4(3)-one derivatives", European Journal of Medicinal Chemistry, (20110524), vol. 46, no. 9, pages 3900 - 3908, XP028278287

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents